Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia
Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…






